Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Science Translational Medicine|February 5, 2016
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomesJoshua T Schiffer, David A Swan, Amalia Magaret, et al.Journal of Innate Immunity|June 9, 2024
TLR9-Dependent Activation by Inactivated Parapoxvirus Ovis in Murine Bone Marrow-Derived Dendritic Cells Is Associated with Specific Strain-Dependent Dendritic Cell SubsetsYanqin Du, Hang Sun, Sonakshi Bhattacharjee, et al.Nature Communications|April 1, 2022
Individual experience as a key to success for the cuckoo catfish brood parasitismHolger Zimmermann, Radim Blažek, Matej Polačik, et al.The Journal of General Virology|September 29, 1999
Integrin alpha(v)beta3 (vitronectin receptor) is a candidate receptor for the virulent echovirus 9 strain BartyBirgit Nelsen-Salz, Hans J Eggers, Holger ZimmermannChaos (Woodbury, N.Y.)|October 2, 2007
Dynamic and static position control of optical feedback solitonsBjörn Gütlich, Holger Zimmermann, Carsten Cleff, et al.Antiviral Research|June 28, 2016
Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovirPeter Lischka, Douglas Zhang, Daniel Holder, et al.Royal Society Open Science|December 13, 2019
Freshwater hydrozoan blooms alter activity and behaviour of territorial cichlids in Lake TanganyikaAneesh P H Bose, Holger Zimmermann, Kristina M SefcBehavioral Ecology : Official Journal of the International Society for Behavioral Ecology|September 25, 2023
Single fathers sacrifice their broods and re-mate quickly in a socially monogamous cichlidHolger Zimmermann, Kristina M Sefc, Aneesh P H BoseAntimicrobial Agents and Chemotherapy|November 6, 2013
Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposureThomas Goldner, Christine Hempel, Helga Ruebsamen-Schaeff, et al.Antimicrobial Agents and Chemotherapy|August 21, 2013
In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitorSteffen Wildum, Daniela Paulsen, Kai Thede, et al.Pageof 7